From the Department of Materials Science and Engineering, the Department of Biomedical Engineering, and the Department of Surgery and Division of Critical Care, Trauma and Burns, The Ohio State University; the Research Department, Shriners Hospitals for Children-Cincinnati; and the Department of Surgery, University of Cincinnati College of Medicine.
Plast Reconstr Surg. 2019 Feb;143(2):310e-321e. doi: 10.1097/PRS.0000000000005270.
Pressure garment therapy, used for reduction of postburn scarring, is commonly initiated after complete healing of the wound or autograft. Although some clinicians have suggested that earlier treatment may improve outcomes, the effect of early initiation of therapy has not been studied in a controlled environment.
Full-thickness burns were created on red Duroc pigs, burn eschar was excised, and the wound bed was grafted with split-thickness autografts. Grafts were treated with pressure garments immediately, 1 week (early), or 5 weeks (delayed) after grafting with nontreated grafts as controls. Scar morphology, biomechanics, and gene expression were measured at multiple time points up to 17 weeks after grafting.
Grafts that received pressure within 1 week after grafting exhibited no reduction in engraftment rates. Immediate and early application of pressure resulted in scars with decreased contraction, reduced scar thickness, and improved biomechanics compared with controls. Pressure garment therapy did not alter expression of collagen I, collagen III, or transforming growth factor β1 at the time points investigated; however, expression of matrix metalloproteinase 1 was significantly elevated in the immediate pressure garment therapy group at week 3, whereas the delayed pressure garment therapy and control groups approached baseline levels at this time point.
Early application of pressure garments is safe and effective for reducing scar thickness and contraction and improving biomechanics. This preclinical study suggests that garments should be applied as soon as possible after grafting to achieve greatest benefit, although clinical studies are needed to validate the findings in humans.
压力衣疗法常用于减少烧伤后瘢痕形成,通常在伤口或自体移植物完全愈合后开始使用。虽然一些临床医生认为早期治疗可能会改善效果,但早期开始治疗的效果尚未在对照环境中进行研究。
在红色杜洛克猪身上造成全层烧伤,切除烧伤焦痂,并将断层自体移植物移植到伤口床上。移植物立即用压力服处理,或在移植后 1 周(早期)或 5 周(延迟)用未处理的移植物作为对照进行处理。在移植后多达 17 周的多个时间点测量瘢痕形态、生物力学和基因表达。
在移植后 1 周内接受压力的移植物没有降低移植物存活率。与对照组相比,立即和早期应用压力导致瘢痕收缩减少、瘢痕厚度减小和生物力学改善。压力衣治疗在研究的时间点没有改变 I 型胶原、III 型胶原或转化生长因子β1 的表达;然而,在第 3 周,立即压力衣治疗组中基质金属蛋白酶 1 的表达显著升高,而延迟压力衣治疗组和对照组在此时接近基线水平。
早期应用压力衣可安全有效地减少瘢痕厚度和收缩,改善生物力学。这项临床前研究表明,尽管需要进行临床研究来验证人类的发现,但应尽快在移植后应用压力衣以获得最大益处。